Efficacy and Safety of Cenerimod in Patients with Moderate to Severe Systemic Lupus Erythematosus (SLE): A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2b Trial

被引：0
|
作者：
Askanase, Anca [1 ]
Berkani, Ouali [2 ]
Cahuzac, Clelia [3 ]
Cornelisse, Peter [3 ]
D'Cruz, David [4 ]
Kalunian, Kenneth [5 ]
Merrill, Joan [6 ]
Pozzobon, Marilia [3 ]
Navarra, Sandra [7 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] IDORSIA, Allschwil, Switzerland
[3] Idorsia Pharmaceut Ltd, Allschwil, Switzerland
[4] Guys & St Thomas NHS Fdn Trust, London, England
[5] Univ Calif San Diego, La Jolla, CA USA
[6] Oklahoma Med Res Fdn, Oklahoma City, OK USA
[7] Univ Santo Tomas, Manila, Philippines
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1656
引用
收藏
页码：3293 / 3297
页数：5
相关论文
共 50 条
  • [1] A multicenter, double-blind, randomized, placebo-controlled, phase IIb dose-finding study to evaluate efficacy and safety of spesolimab in patients with moderate-to-severe palmoplantar pustulosis
    Burden, A. David
    Bissonnette, Robert
    Navarini, Alexander A.
    Murakami, Masamoto
    Morita, Akimichi
    Mozzicato, Susan
    Ye, Binqi
    Baehner, Frank
    Terui, Tadashi
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB131 - AB131
  • [2] Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial
    Zhao, Yan
    Zhang, Jianzhong
    Yang, Bin
    Li, Jingyi
    Ding, Yangfeng
    Wu, Liming
    Zhang, Litao
    Wang, Jinyan
    Zhu, Xiaohong
    Zhang, Furen
    Tao, Xiaohua
    Li, Yumei
    Zhang, Chunlei
    Li, Linfeng
    Lu, Jianyun
    Diao, Qingchun
    Lu, Qianjin
    Man, Xiaoyong
    Li, Fuqiu
    Xia, Xiujuan
    Cheng, Hao
    Jia, Yingmin
    Zhao, Guoqing
    Yan, Jinchun
    Chen, Bo
    [J]. CHINESE MEDICAL JOURNAL, 2024, 137 (02) : 200 - 208
  • [3] Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial
    Zhao Yan
    Zhang Jianzhong
    Yang Bin
    Li Jingyi
    Ding Yangfeng
    Wu Liming
    Zhang Litao
    Wang Jinyan
    Zhu Xiaohong
    Zhang Furen
    Tao Xiaohua
    Li Yumei
    Zhang Chunlei
    Li Linfeng
    Lu Jianyun
    Diao Qingchun
    Lu Qianjin
    Man Xiaoyong
    Li Fuqiu
    Xia Xiujuan
    Cheng Hao
    Jia Yingmin
    Zhao Guoqing
    Yan Jinchun
    Chen Bo
    [J]. 中华医学杂志(英文版), 2024, 137 (02)
  • [4] A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Not on Concomitant Methotrexate.
    Genovese, Mark C.
    Greenwald, Maria
    Codding, Christine
    Cardiel, Mario H.
    Zubrzycka-Sienkiewicz, Anna
    Kivitz, Alan J.
    Wisseh, Steve
    Shay, Kathyjo
    Garg, Jay P.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1234 - S1235
  • [5] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM TWO RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDIES
    Morand, E. F.
    Tanaka, Y.
    Furie, R.
    Vital, E.
    van Vollenhoven, R.
    Kalunian, K.
    Mosca, M.
    Doerner, T.
    Wallace, D. J.
    Silk, M.
    Dickson, C.
    De la Torre, I.
    Meszaros, G.
    Jia, B.
    Crowe, B.
    Petri, M. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 327 - 328
  • [6] Efficacy and safety of Dimdazenil in the adult insomnia patients: a phase II randomized, multicenter, double-blind, placebo-controlled, and parallel-group study
    Li, Yanpeng
    Zhang, Ruoxi
    Zhou, Yanling
    Bao, Cungang
    Lin, Zhaocun
    Chen, Chunyan
    He, Jingjing
    Jin, Zhiping
    Song, Lihua
    Zhang, Min
    Guo, Sigen
    Jiang, Yu
    Zhao, Zhongxin
    [J]. SLEEP, 2024, 47 (02)
  • [7] A randomized, double-blind, parallel-group, placebo-controlled Phase 3 trial to evaluate efficacy and safety of ocrelizumab in PPMS
    Montalban, Xavier
    Hemmer, Bernhard
    Rammohan, Kottil W.
    Giovannoni, Gavin
    De Seze, Jerome
    Bar-Or, Amit
    Arnold, Douglas L.
    Sauter, Annette
    Masterman, Donna
    Fontoura, Paulo
    Chin, Peter
    Garren, Hideki
    Wolinsky, Jerry S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 17 - 17
  • [8] Cabergoline in RLS - A double-blind placebo-controlled multicenter dose-finding trial
    Stiasny, K
    Ueberal, MA
    Oertel, WH
    [J]. SLEEP, 2002, 25 : A489 - A489
  • [9] Cabergoline in RLS: A double-blind, placebo-controlled, multicenter, dose-finding trial
    Stiasny, K
    Ueberall, MA
    Oertel, WH
    [J]. NEUROLOGY, 2002, 58 (07) : A435 - A435
  • [10] Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial
    Wu, Di
    Li, Jing
    Xu, Dong
    Merrill, Joan T.
    van Vollenhoven, Ronald F.
    Liu, Yi
    Hu, Jiankang
    Li, Yang
    Li, Fen
    Huang, Chenghui
    Wang, Guochun
    Li, Xiaomei
    Zhao, Jianhong
    Zhao, Dongbao
    Huang, Cibo
    Liu, Huaxiang
    Wei, Wei
    Shi, Guixiu
    Lu, Fuai
    Zuo, Xiaoxia
    Bi, Liqi
    Li, Zhijun
    Wang, Xiaoxia
    Zhang, Miaojia
    Tie, Ning
    Li, Juan
    Mo, Hanyou
    Fang, Jianmin
    Bao, Chunde
    Zhang, Fengchun
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (04) : 475 - 487
12345